Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$1,640,820
+$405,569 QoQ
Shares Held
1,368
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.04%
of 13F equity value
Holder Rank
#2,683
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gleason Group, Inc. holds $4,846,851 across 10 Drug Manufacturers - General names. LLY ranks #2 (33.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,605 | $1,677,471 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,368 | $1,640,820 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
9,418 | $1,189,870 | |
| 4 | AMGN |
Amgen Inc
|
389 | $140,864 | |
| 5 | MRK |
Merck & Co., Inc.
|
899 | $115,521 | |
| 6 | ABBV |
AbbVie Inc.
|
220 | $55,360 | |
| 7 | NVS |
Novartis AG
|
62 | $9,716 | |
| 8 | AZN |
Astrazeneca PLC
|
40 | $7,584 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,640,820 | 1,368 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $1,235,251 | 1,343 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,581,929 | 1,472 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,179,598 | 1,546 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,202,814 | 1,543 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,271,901 | 1,540 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,187,336 | 1,538 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,992,479 | 2,249 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,035,294 | 2,248 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,746,520 | 2,245 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,307,489 | 2,243 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,226,267 | 2,283 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,068,336 | 2,278 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $780,593 | 2,273 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $710,461 | 1,942 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $626,005 | 1,936 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $625,763 | 1,930 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $550,975 | 1,924 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $529,513 | 1,917 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $441,305 | 1,910 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $437,006 | 1,904 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $354,210 | 1,896 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $318,938 | 1,889 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $367,533 | 2,483 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $441,480 | 2,689 | Shares | Sole | 2020-08-27 | |
| 2020-03-31 | $385,086 | 2,776 | Shares | Sole | 2020-08-27 | |
| No filing history on record for this holder in this stock. | ||||||